COMMUNIQUÉS West-GlobeNewswire

Sensus Healthcare Reports Second Quarter 2019 Financial Results
08/08/2019
· Resumes double-digit revenue growth, up 23% over the prior year quarter · Affirms expectations for full-year double-digit revenue growth · Conference call begins at 4:30 p.m. East ern time today BOCA RATON, Fla., Aug [...]
Helius Medical Technologies, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
08/08/2019
NEWTOWN, Pa., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial [...]
Osmotica Pharmaceuticals plc Reports Second Quarter 2019 Results
08/08/2019
Second quarter 2019 total revenue of $57.5 million On track to submit NDA for RVL-1201 (oxymetazoline hydrochloride ophthalmic solution, 0.1%) for acquired blepharoptosis, or droopy eyelid, by end of Q3 2019 BRIDGEWATER [...]
Rockwell Medical, Inc. Reports Second Quarter 2019 Financial Results
08/08/2019
– Company Records First Commercial Sales of Dialysate Triferic®; FDA Accepts New Drug Application for I.V. Triferic with PDUFA date of March 28, 2020 – WIXOM, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, [...]
Marrone Bio announces transformative acquisition of Pro Farm Technologies in the $4.6 billion seed- and soil-treatment market
08/08/2019
Pro Farm products expected to substantially accelerate growth trajectory DAVIS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (NASDAQ: MBII), an international leader in sustainable [...]
Marrone Bio announces financing facility to fund future operations and strategic acquisitions
08/08/2019
DAVIS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today that it has established a $ [...]
FibroGen Reports Second Quarter 2019 Financial Results
08/08/2019
— On Track to Submit U.S. NDA for Roxadustat in October — — Initiated ZEPHYRUS Phase 3 Study of Pamrevlumab in IPF — Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time SAN FRANCISCO, Aug. 08, 2019 ( [...]
Tabula Rasa HealthCare Announces Second Quarter 2019 Operating Results
08/08/2019
Second Quarter 2019 Revenue of $76.3 million, growth of 57%; 2019 Guidance Increased MOORESTOWN, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology [...]
Adamas Reports Second Quarter 2019 Financial Results
08/08/2019
- Second quarter GOCOVRI® product sales of $12.7 million; total prescriptions grew to approximately 6,160 - INROADS Phase 3 study of ADS-5102 (GOCOVRI) for walking impairment in patients with multiple sclerosis (MS) [...]
Principia Biopharma Reports Second Quarter Financial Results
08/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
TearLab Corporation Reports Second Quarter and First Half 2019 Financial Results
08/08/2019
ESCONDIDO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter ended June 30, 2019. All [...]
Oncternal Reports Second Quarter 2019 Financial Results and Provides Business Update
08/08/2019
SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Interim objective response rate of 100% in evaluable patients with CLL receiving the recommended dosing regimen of cirmtuzumab + ibrutinib supports opening Phase 2 Two [...]
MacroGenics to Participate in Upcoming Investor Conferences
08/08/2019
Rockville, MD, Aug. 08, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Bio-Path Holdings to Announce Second Quarter 2019 Financial Results on August 15, 2019
08/08/2019
HOUSTON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Sientra Reports Second Quarter 2019 Financial Results
08/08/2019
Record total net sales of $20.5 million in 2Q19, growth of 17% year over year Breast Products net sales of $11.2 million in 2Q19, growth of 19% year over year Record miraDry net sales of $9.3 million in 2Q19, growth of [...]
Immuron Reports Results in Severe Alcoholic Hepatitis Clinical Trial
08/08/2019
MELBOURNE, Australia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the [...]
Visual Healthcare Corp. (OTC: VSHC) Announces New Name
08/08/2019
VSHC Is Now Movement Industries Corporation Houston, TX, Aug. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Visual Healthcare Corp. (OTC PINK: VSHC) VSHC/LTN Capital is excited to announce its new name, Movement [...]
Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2019
08/08/2019
Company Release no. 12/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 08 August 2019 Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2019 Veloxis Pharmaceuticals A/S (OMX: VELO) [...]
Nurses and Nurse Practitioners of British Columbia (NNPBC) and the Harm Reduction Nurses Association (HRNA) call for the decriminalization of people who use drugs in B.C.
08/08/2019
The following is a statement issued by the Nurses and Nurse Practitioners of British Columbia (NNPBC) and the Harm Reduction Nurses Association (HRNA). Canada is in the midst of a public health emergency with more than [...]

Pages